From Medscape Gastroenterology

Medscape Medical News from:

The Liver Meeting 2013: American Association for the Study of Liver Diseases (AASLD)

November 01 - 05, 2013; Washington, DC

This coverage is not sanctioned by, nor a part of, the American Association for the Study of Liver Diseases.

Conference News

AASLD Hepatitis C Viral Suppression Reduces Liver Morbidity, Death
Medscape Medical News, November 15, 2013
AASLD Primary Care Option for Hepatitis C Treatment Cost-Effective
Medscape Medical News, November 14, 2013
AASLD Costs for Hepatitis C Treatment Skyrocket
Medscape Medical News, November 13, 2013
AASLD Surge of Liver Cancer Patients on Transplant Waitlists
Medscape Medical News, November 12, 2013
AASLD Promising New Era in Hepatitis C Treatment
Medscape Medical News, November 11, 2013
AASLD Studies Support Baby Boomer Hepatitis C Screening
Medscape Medical News, November 8, 2013
AASLD Hepatotoxicity From Bodybuilding Supplements Rising
Medscape Medical News, November 6, 2013
AASLD Global Burden of Liver Disease Substantial
Medscape Medical News, November 4, 2013
AASLD Many Liver Transplant Patients Unable to Afford Meds
Medscape Medical News, November 3, 2013
AASLD Hepatitis C to Take Center Stage at the Liver Meeting
Medscape Medical News, October 28, 2013

Medscape Gastroenterology© WebMD, LLC

Expert Commentary

Top 10 Highlights From The Liver Meeting
William F. Balistreri, MD

Previous Coverage

The Liver Meeting 2012

The Liver Meeting 2011

The Liver Meeting 2010